The present invention relates to new sulfonamide URAT-1 inhibitor compounds of formula (I) or pharmaceutically acceptable salts thereof:to compositions containing them, to processes for their preparation and to intermediates used in such processes and to methods of treatment； wherein R1, R2, R3, R4, R5 and R6 are as defined in the description.
